BMS And Scripps Join For Drug Discovery | Chemical & Engineering News
Volume 90 Issue 26 | p. 21 | Concentrates
Issue Date: June 25, 2012

BMS And Scripps Join For Drug Discovery

Department: Business
Keywords: industry-academic collaboration, drug discovery, click chemistry

Bristol-Myers Squibb and Scripps Research Institute have entered a five-year pact to apply novel chemistry to drug discovery and synthesis. Under the agreement, Scripps investigators will prepare synthetic intermediates and analogs for biological evaluation against BMS targets. Separately, Scripps has licensed click chemistry developed by Nobel Laureate K. Barry Sharpless to Sutro Biopharma, a South San Francisco-based firm that will use the technology to synthesize therapeutic proteins.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment